Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Treatment With the PathMaker Myoregulator Neuromodulation System Incorporating Trans-spinal Direct Current Stimulation (tsDCS) in Patients With Severe Hand Spasticity After Stroke

NCT03080454 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.

NCT NCT03080454
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03080454 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Treatment With the PathMaker Myoregulator Neuromodulation System Incorporating Trans-spinal Direct Current Stimulation (tsDCS) in Patients With Severe Hand Spasticity After Stroke
Lead sponsor
Northwell Health
Phase
Phase 1/2
Overall status
Completed
Start date
September 30, 2016
Completion date
March 31, 2018
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrovascular accident (cva), hemiparesis, muscle spasticity, spasticity as sequela of stroke, stroke, upper extremity paralysis